✦ LIBER ✦

Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia

✍ Scribed by Enriqueta Albizua; Miguel Gallardo; Santiago Barrio; Inmaculada Rapado; Ana Jimenez; Rosa Ayala; Daniel Rueda; Beatriz Sanchez-Espiridion; Eulalia Puigdecanet; Blanca Espinet; Lourdes Florensa; Carles Besses; Joaquin Martinez-Lopez

Book ID: 105989817
Publisher: Springer
Year: 2011
Tongue: English
Weight: 296 KB
Volume: 90
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-011-1179-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the JAK2-V617F gene mutati

Evaluation of the JAK2-V617F gene mutation in Turkish patients with essential thrombocythemia and polycythemia vera

✍ Karkucak, Mutlu; Yakut, Tahsin; Ozkocaman, Vildan; Ozkalemkas, Fahir; Ali, Ridva 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 193 KB

Observation of a higher JAK2 V617F homoz

Observation of a higher JAK2 V617F homozygous mutated clone in polycythemia vera compared to essential thrombocythemia

✍ Liu, Hongxing ;Tong, Chunrong ;Cai, Peng ;Gu, Jiangying ;Lin, Yuehui ;Zhang, Yin 📂 Article 📅 2008 🏛 Higher Education Press and Springer 🌐 English ⚖ 103 KB

Hydroxyurea (HU) is effective in reducin

Hydroxyurea (HU) is effective in reducing JAK2V617F mutated clone size in the peripheral blood of essential thrombocythemia (ET) and polycythemia vera (PV) patients

✍ Emmanouil Spanoudakis; Ioanna Bazdiara; Ioannis Kotsianidis; Dimitrios Margariti 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 174 KB

1031 Differential Gene Expression Profil

1031 Differential Gene Expression Profile in Response to the Treatment With JAK2 Inhibitors – Ruxolitinib, SAR302503 and LY2784544

✍ P. Gunerka; B. Dymek; D. Zdzalik; P. Grygielewicz; K. Dzwonek; M. Lamparska-Przy 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB